Provision of exercise services in patients with peripheral artery disease in the United Kingdom.
Peripheral artery disease
best practice
intermittent claudication
survey
Journal
Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
pubmed:
6
8
2021
medline:
21
9
2022
entrez:
5
8
2021
Statut:
ppublish
Résumé
Supervised exercise programmes (SEPs) are a vital treatment for people with intermittent claudication, leading improvements in walking distance and quality of life and are recommended in multiple national and international guidelines. We aimed to evaluate the use and structure of SEPs in the United Kingdom (UK). We conducted an anonymous online survey using the Jisc platform comprising of 40 questions. The survey was designed to address key areas such as access, provision, uptake and delivery of SEPs in the United Kingdom. Ethical approval was obtained from Coventry University (P108729). The list of trusts providing vascular services was obtained from the National Vascular Registry (NVR) report. The survey was disseminated via social media, The Vascular Society of Great Britain and Ireland and the Society for Vascular Technology. Data were exported to a Microsoft Excel document and analysed using simple descriptive statistics. Of 93 vascular units identified, we received response from 48. Of these, 23 had access to an exercise programme (48%). The majority of SEPs were exclusively for PAD patients (77%), with 21% using integrated services. 67% of respondents were providing a circuit-based programme, and 5 out of 23 were meeting the dose recommendations in the UK National Institute for Health and Care Excellence (NICE) guidelines. Respondents felt that programmes were moderately to extremely important to patients, slightly to very important to clinicians and not at all important to slightly important to commissioning/funding bodies. SEPs are a well-established first-line treatment for patients with IC and they are recommended by NICE guidelines. Despite this, many patients still do not have access to an exercise programme, and clinicians do not feel that they have support from commissioning/funding bodies to develop them. There is an urgent need for funding, development and delivery of SEPs in the United Kingdom.
Identifiants
pubmed: 34348503
doi: 10.1177/17085381211035259
pmc: PMC9485155
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
874-881Références
Atherosclerosis. 2006 Aug;187(2):221-37
pubmed: 16386260
Circulation. 2014 Jul 1;130(1):69-78
pubmed: 24982118
Circulation. 2019 Jan 22;139(4):e10-e33
pubmed: 30586765
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030
pubmed: 31303293
Eur J Prev Cardiol. 2019 Oct;26(15):1625-1633
pubmed: 31216860
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Vasc Surg. 2017 Oct;66(4):1241-1257
pubmed: 28822657
Ann R Coll Surg Engl. 2009 Sep;91(6):473-6
pubmed: 19558766
J Am Heart Assoc. 2020 Feb 4;9(3):e012541
pubmed: 31973609
Cochrane Database Syst Rev. 2018 Apr 06;4:CD005263
pubmed: 29627967
BMJ Open Sport Exerc Med. 2020 Nov 5;6(1):e000897
pubmed: 33262892
J Vasc Surg. 2012 May;55(5):1346-54
pubmed: 22459748
Circ J. 2017 Feb 24;81(3):281-289
pubmed: 28123169
Br J Surg. 2019 Mar;106(4):319-331
pubmed: 30791089
J Vasc Surg. 2021 Dec;74(6):2076-2085.e20
pubmed: 34087396
Br J Sports Med. 2020 Apr;54(8):452-461
pubmed: 30979698
Heart Lung Circ. 2021 Jul;30(7):1031-1043
pubmed: 33593677
Contemp Clin Trials Commun. 2019 May 27;15:100389
pubmed: 31388598
Ann Vasc Surg. 2011 Feb;25(2):182-90
pubmed: 20889294
Kardiol Pol. 2017;75(11):1065-1160
pubmed: 29589371
Ann Vasc Surg. 2016 Jul;34:280-9
pubmed: 27126713
Cochrane Database Syst Rev. 2017 Dec 26;12:CD000990
pubmed: 29278423
J Vasc Surg. 2020 May;71(5):1702-1707
pubmed: 31699514
Ther Adv Cardiovasc Dis. 2020 Jan-Dec;14:1753944720924270
pubmed: 32459138